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were evacuated for disease, 20% for nonbattle injuries, 19% for battle injuries, and 2% unknown.Â ir Mobility Command (AMC), the U.S. Transportation Command (USTRANSCOM) component responsible for providing intertheater and intratheater AE, currently moves patients with certain infectious diseases such as those with low epidemic risk. Although AMC transports some contagious patients routinely using appropriate infection control, the operational decision to evacuate patients with infectious diseases is complicated by many factors, including the etiologic agent involved. Eor example, in-flight influenza infections are likely to spread with great efficiency because of close proximity and closed environmental conditions. During a long international flight, some of the crew and passengers may become symptomatic because of a recent exposure, with multiple secondary cases then arising from the transport.
To address concerns and issues related to transportation and public health management of contagious individuals One hundred professionals from CONUS and OCONUS military installations, combatant commands (COCOMs), military medical institutions, service public health hubs, the Pentagon, and other members of the public health conrmiunity participated. The participants included not only senior leaders and policymakers but also a diverse mix of frontline practitioners including physicians, environmental scientists, nurses, medical planners, and others. Approximately one-third were public health emergency officers (PHEOs) or alternate PHEOs. Participants represented each of the services as well as all the geographic COCOMs.
A central focus of workshop presentations and discussions related to current USTRANSCOM policy on movement of highly contagious patients. This policy dictates that patients with known or suspected infection with a highly contagious disease will not be transported within the patient movement system, but rather will be treated "in place" or with minimal transportation to medical authorities.' These include infections with any agent that could present a national security threat, require special public health actions, or potentiate public panic and social disruption.' The "treat in place" approach may thus entail movement of medical resources to locations of need.
The discussions uncovered certain issues in present USTRANSCOM policy regarding patient movement with significant implications for U.S. military policy, planning, and operations in the present influenza pandemic. One such policy issue is the current absence of a clearly defined, specific "trigger"-based on case fatality rate, morbidity levels, or otherwise-for transitioning to the USTRANSCOM policy on highly contagious patient movement. After consideration of the current characteristics of the influenza A (HlNl) virus (i.e., that most cases of HlNl cause mild to moderate illness), USTRANSCOM has deemed that patient movement for suspected, probable, or confirmed HlNl does not yet fall under the policy and does not require approval from the Secretary of Defense."-' The August 17 workshop participants, however.
raised operational concerns about the threshold at which this policy might take effect in the context of the current influenza A (H1N1 ) pandemic. Given the capacity of influenza viruses to mutate rapidly (with potential for greater severity), this gap in current USTRANSCOM policy is a timely and salient issue.
The August 17 workshop also raised a series of criticaland currently unanswered-questions that would apply if and when the USTRANSCOM treatment in place policy does take effect for patients with pandemic influenza A (HlNl) infection. What specific surge capacity management strategies should these treatment facilities employ in the context of treating in place? What altered standards of care would apply in the face of diminished healthcare resources (e.g., antibiotics, antiviral drugs, ventilators)? If a given installation's treatment resources were to become depleted, what inter-and intra-COCOM mechanisms would be used to transfer assets from less affected to more affected areas? How would a host nation's airspace prohibitions or relevant disease mitigation restrictions impact USTRANSCOM's treatment in place policy? These critical questions require timely answers, accompanied by enhanced emphasis on inventorying of medical assets during this rapidly narrowing planning window.
USTRANSCOM's treatment in place policy is a fundamentally localized model for infectious disease management, consistent with the maxim that "all disasters begin locally." Addressing the above questions and issues raised at the August 17 workshop will necessitate broad and efficient dissemination of policy clarifications to all stakeholders DoDwide, including installations, which represent the localized front lines of the treatment in place model. Such policy clarifications will require both specificity and flexibility, accounting for the epidemiologic reality that different locations within different COCOMS will likely experience different pandemic disease burdens at different times during the course of current and future pandemics.
